Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Vectura Group PLC Add to portfolio

FTAL:VEC, Sep 21, 03:35 UTC

Latest FTAL:VEC News

Filter your feed

Apply Filter

Friday, September 13


News

Vectura provides update on GSK Litigation

VEC GSK

Paul Fry, Vectura’s Chief Financial Officer and Interim Chief Executive Officer of Vectura, said: “The judge’s post-motions ruling further validates Vectura’s original decision to pursue this action with GSK. We will always take action to protect and defend our intellectual property and we will provide further updates on this matter in due course.”. This interest will accrue on the damages awarded by the jury, supplemental damages and prejudgment interest, and will accrue going forward until Vectura is compensated by GSK. Judge Andrews denied the following motions: GSK’s motion for judgment of non-infringement, GSK’s motion for judgment of obviousness, GSK’s motion for a finding of no wilful infringement, GSK’s motion for a new trial, GSK’s motion for a reduction in the amount of damages awarded by the jury, Vectura’s motion for enhanced damages, and Vectura’s motion for attorney’s fees.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, September 11


News

Vectura Group (LON:VEC) Rating Reiterated by Peel Hunt – Slater Sentinel

VEC

Vectura Group (LON:VEC)‘s stock had its “hold” rating reiterated by equities research analysts at Peel Hunt in a research report issued on Monday, ThisIsMoney.Co.Uk reports. Finally, Morgan Stanley reiterated a “buy” rating and set a GBX 160 ($2.09) target price on shares of Vectura Group in a research report on Friday, May 24th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Vectura Group stock opened at GBX 79.70 ($1.04) on Monday.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Tuesday, September 10


News

Vectura Group plc: Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Dividend Reinvestment Plan

VEC

"Today we’re announcing our intention to increase our capital return from £50 million to £60 million reflecting our belief in a strong outlook and the cash generative nature of our business. Following feedback from our major shareholders, we believe the proposal of a special dividend coupled with an on-market share buyback programme delivers the right balance of speed and efficiency, whilst providing liquidity for the stock during a period of potential uncertainty in financial market conditions." JPMS will make its trading decisions in relation to the Share Buyback Programme independently of, and uninfluenced by, Vectura. The Company will announce any buyback of New Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the buyback occurred. Any valid applications or elections received after this time will not apply to the Special Dividend.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, August 28


News

Vectura Group (OTCMKTS:VEGPF) Stock Price Down 3.1% – Slater Sentinel

VEC

Vectura Group PLC (OTCMKTS:VEGPF)’s stock price traded down 3.1% during trading on Monday . The company traded as low as $0.95 and last traded at $0.95, 0 shares changed hands during mid-day trading. Separately, ValuEngine downgraded shares of Vectura Group from a “hold” rating to a “sell” rating in a research report on Wednesday, July 24th. Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Wednesday, July 17


News

Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading update

VEC

Chippenham, UK – 17 July 2019: Vectura Group plc (VEC.L) ("Vectura" or "the Group") today confirms its R&D investment priorities, announces a proposed £50 million capital return and provides an unaudited pre-close trading update. “Given the Group’s focus is now primarily on organic growth, with lower risk R&D spend supported by partners, it is our intention to return £50 million to shareholders this year, with the Board continuing to review our capital allocation strategy on a regular basis. Following the successful build out of its generics portfolio, Vectura will continue to focus on securing new partner contracts for the development of inhaled therapies, including novel molecules. For these contracts the Group will move towards offering development services where a smaller proportion of the overall contract value is delivered through contingent milestones. In light of the Group’s reducing R&D risk profile, future cash generation expectations and strong cash balance, the Board has approved, in principle, a capital return of approximately £50 million, commencing in 2019.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, July 06


News

Vectura Group PLC (LON:VEC) Given Consensus Recommendation of “Buy” by Analysts – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is GBX 125.75 ($1.64). JPMorgan Chase & Co. reduced their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an “overweight” rating for the company in a research report on Wednesday, April 3rd.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, July 04


News

Vectura Group PLC (LON:VEC) Given Average Rating of “Buy” by Brokerages – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have earned a consensus rating of “Buy” from the seven brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is GBX 125.75 ($1.64). Peel Hunt reduced their target price on shares of Vectura Group from GBX 107 ($1.40) to GBX 105 ($1.37) and set a “hold” rating for the company in a research note on Tuesday, March 12th.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Saturday, June 29


News

Vectura Group PLC (LON:VEC) Given Consensus Recommendation of “Buy” by Analysts – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is GBX 125.75 ($1.64). JPMorgan Chase & Co. reduced their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an “overweight” rating for the company in a research report on Wednesday, April 3rd.

Read Full Details

Topics:
  • Business
  • Financial
  • Health

Monday, June 17


News

Vectura Group (LON:VEC) Receives Buy Rating from Numis Securities – Rockland Register

VEC

Finally, JPMorgan Chase & Co. cut their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an overweight rating on the stock in a research report on Wednesday, April 3rd. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Shares of LON VEC traded up GBX 0.40 ($0.01) during midday trading on Friday, reaching GBX 81.40 ($1.06). Vectura Group has a 52 week low of GBX 65.85 ($0.86) and a 52 week high of GBX 90.15 ($1.18).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Sunday, June 16


News

Morgan Stanley Reiterates “Equal Weight” Rating for Cincinnati Bell (NYSE:CBB) – Rockland Register

VEC MS

Cincinnati Bell (NYSE:CBB)‘s stock had its “equal weight” rating reiterated by stock analysts at Morgan Stanley in a note issued to investors on Friday, June 7th, FirstToMarketsRatingsTable reports. They presently have a $8.00 price objective on the utilities provider’s stock, down from their previous price objective of $10.00. Separately, ValuEngine upgraded Cincinnati Bell from a “sell” rating to a “hold” rating in a research report on Wednesday, March 20th. The firm’s revenue was up 28.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Cincinnati Bell will post -1.13 EPS for the current year.

Read Full Details

Topics:
  • Business
  • Financial
  • Health